Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:19 AM
Ignite Modification Date:
2025-12-25 @ 3:19 AM
NCT ID:
NCT04857905
Eligibility Criteria:
Inclusion Criteria:
* Patients over 18 years and under 90 years
* Patients with KPS ≥70
* Patients with NSCLC, melanoma, breast cancer or renal cancer as primary tumor
* Maximum of three brain metastases on the diagnostic MRI
* Tumor volume of 8-20 ccm3 on the diagnostic MRI
* Lobular brain metastases
* Patients without any contraindications for both treatment options
* Written, signed informed consent for study particaption after study explanation
Exclusion Criteria:
* Patients under 18 years and over 90 years
* Patients with KPS \<70
* Patients with other primary tumor
* More than three brain metastases on the diagnostic MRI
* Tumor volume \<8 or \>20 ccm3 on the diagnostic MRI
* Patients with contraindications for both treatment options
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
90 Years
Study:
NCT04857905
Study Brief:
Protocol Section:
NCT04857905